GIVAX, Inc.

GIVAX, Inc.

生物技术研究

Working to eliminate the burden of GI disease in children & adults through the development of novel oral vaccines.

关于我们

GIVAX, Inc. is a biotech company that is backed by RA Ventures, the venture-focused arm of RA Capital Management, LP. GIVAX is developing novel oral vaccines to eliminate the burden of preventable GI disease in children & adults. Our lead program is a dual pediatric rotavirus / norovirus vaccine.

所属行业
生物技术研究
规模
2-10 人
类型
私人持股
创立
2021

GIVAX, Inc.员工

动态

相似主页